Xermelo Approved for Tumor-Related Diarrhea

WEDNESDAY, March 1, 2017 — Xermelo (telotristat ethyl) tablets have been approved by the U.S. Food and Drug Administration to treat adults with carcinoid syndrome diarrhea, one of a collection of symptoms related to rare carcinoid tumors.
Most of…
Source: Topamax